These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 27746275)

  • 21. Intracellular PK/PD Relationships of Free and Liposomal Doxorubicin: Quantitative Analyses and PK/PD Modeling.
    Soininen SK; Vellonen KS; Heikkinen AT; Auriola S; Ranta VP; Urtti A; Ruponen M
    Mol Pharm; 2016 Apr; 13(4):1358-65. PubMed ID: 26950248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin.
    Arabi L; Badiee A; Mosaffa F; Jaafari MR
    J Control Release; 2015 Dec; 220(Pt A):275-286. PubMed ID: 26518722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Membrane-Loaded Doxorubicin Liposomes Based on Ion-Pairing Technology with High Drug Loading and pH-Responsive Property.
    Xu H; Zhang L; Li L; Liu Y; Chao Y; Liu X; Jin Z; Chen Y; Tang X; He H; Kan Q; Cai C
    AAPS PharmSciTech; 2017 Aug; 18(6):2120-2130. PubMed ID: 28028795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous active intracellular delivery of doxorubicin and C6-ceramide shifts the additive/antagonistic drug interaction of non-encapsulated combination.
    Fonseca NA; Gomes-da-Silva LC; Moura V; Simões S; Moreira JN
    J Control Release; 2014 Dec; 196():122-31. PubMed ID: 25305563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
    Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW
    Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequential HIFU heating and nanobubble encapsulation provide efficient drug penetration from stealth and temperature sensitive liposomes in colon cancer.
    VanOsdol J; Ektate K; Ramasamy S; Maples D; Collins W; Malayer J; Ranjan A
    J Control Release; 2017 Feb; 247():55-63. PubMed ID: 28042085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient tumor regression by a single and low dose treatment with a novel and enhanced formulation of thermosensitive liposomal doxorubicin.
    Tagami T; Ernsting MJ; Li SD
    J Control Release; 2011 Jun; 152(2):303-9. PubMed ID: 21338635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combining activatable nanodelivery with immunotherapy in a murine breast cancer model.
    Kheirolomoom A; Silvestrini MT; Ingham ES; Mahakian LM; Tam SM; Tumbale SK; Foiret J; Hubbard NE; Borowsky AD; Ferrara KW
    J Control Release; 2019 Jun; 303():42-54. PubMed ID: 30978432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C8-glycosphingolipids preferentially insert into tumor cell membranes and promote chemotherapeutic drug uptake.
    Cordeiro Pedrosa LR; van Cappellen WA; Steurer B; Ciceri D; ten Hagen TL; Eggermont AM; Verheij M; Goñi FM; Koning GA; Contreras FX
    Biochim Biophys Acta; 2015 Aug; 1848(8):1656-70. PubMed ID: 25917957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models.
    Chi Y; Yin X; Sun K; Feng S; Liu J; Chen D; Guo C; Wu Z
    J Control Release; 2017 Sep; 261():113-125. PubMed ID: 28666726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity.
    Jung SH; Jung SH; Seong H; Cho SH; Jeong KS; Shin BC
    Int J Pharm; 2009 Dec; 382(1-2):254-61. PubMed ID: 19666094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamic contrast enhanced MRI detects changes in vascular transport rate constants following treatment with thermally-sensitive liposomal doxorubicin.
    Fite BZ; Kheirolomoom A; Foiret JL; Seo JW; Mahakian LM; Ingham ES; Tam SM; Borowsky AD; Curry FE; Ferrara KW
    J Control Release; 2017 Jun; 256():203-213. PubMed ID: 28395970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The antitumor activity of tumor-homing peptide-modified thermosensitive liposomes containing doxorubicin on MCF-7/ADR: in vitro and in vivo.
    Wang C; Wang X; Zhong T; Zhao Y; Zhang WQ; Ren W; Huang D; Zhang S; Guo Y; Yao X; Tang YQ; Zhang X; Zhang Q
    Int J Nanomedicine; 2015; 10():2229-48. PubMed ID: 25834435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-time fluorescence imaging for visualization and drug uptake prediction during drug delivery by thermosensitive liposomes.
    Motamarry A; Negussie AH; Rossmann C; Small J; Wolfe AM; Wood BJ; Haemmerich D
    Int J Hyperthermia; 2019; 36(1):817-826. PubMed ID: 31451077
    [No Abstract]   [Full Text] [Related]  

  • 35. Pulsed-high intensity focused ultrasound and low temperature-sensitive liposomes for enhanced targeted drug delivery and antitumor effect.
    Dromi S; Frenkel V; Luk A; Traughber B; Angstadt M; Bur M; Poff J; Xie J; Libutti SK; Li KC; Wood BJ
    Clin Cancer Res; 2007 May; 13(9):2722-7. PubMed ID: 17473205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanistic insights into the intracellular release of doxorubicin from pH-sensitive liposomes.
    Dos Reis SB; de Oliveira Silva J; Garcia-Fossa F; Leite EA; Malachias A; Pound-Lana G; Mosqueira VCF; Oliveira MC; de Barros ALB; de Jesus MB
    Biomed Pharmacother; 2021 Feb; 134():110952. PubMed ID: 33348307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CpG expedites regression of local and systemic tumors when combined with activatable nanodelivery.
    Kheirolomoom A; Ingham ES; Mahakian LM; Tam SM; Silvestrini MT; Tumbale SK; Foiret J; Hubbard NE; Borowsky AD; Murphy WJ; Ferrara KW
    J Control Release; 2015 Dec; 220(Pt A):253-264. PubMed ID: 26471394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperthermia mediated liposomal drug delivery.
    Ponce AM; Vujaskovic Z; Yuan F; Needham D; Dewhirst MW
    Int J Hyperthermia; 2006 May; 22(3):205-13. PubMed ID: 16754340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The release of Doxorubicin from liposomes monitored by MRI and triggered by a combination of US stimuli led to a complete tumor regression in a breast cancer mouse model.
    Rizzitelli S; Giustetto P; Faletto D; Delli Castelli D; Aime S; Terreno E
    J Control Release; 2016 May; 230():57-63. PubMed ID: 27049069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Robust, tumor-homing and redox-sensitive polymersomal doxorubicin: A superior alternative to Doxil and Caelyx?
    Zou Y; Meng F; Deng C; Zhong Z
    J Control Release; 2016 Oct; 239():149-58. PubMed ID: 27569664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.